{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:46:44Z","timestamp":1792403204271,"version":"4.4.0"},"reference-count":25,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"Wu Jieping Medical Foundation","award":["320.6750.2024\u201318-82"],"award-info":[{"award-number":["320.6750.2024\u201318-82"]}]},{"name":"Hospital Pharmacy Research Foundation of Guangdong Province","award":["2025A03030"],"award-info":[{"award-number":["2025A03030"]}]},{"name":"Clinical Drug Use Research Foundation of Guangdong Province","award":["2022JZ33"],"award-info":[{"award-number":["2022JZ33"]}]},{"name":"Clinical Drug Use Research Foundation of Guangdong Province","award":["2024A02029"],"award-info":[{"award-number":["2024A02029"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncology"],"DOI":"10.1080\/14796694.2026.2750655","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:23:04Z","timestamp":1792401784000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["First-line osimertinib with or without chemotherapy for EGFR-mutant advanced NSCLC in China: a cost-effectiveness analysis"],"prefix":"10.1080","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0802-1661","authenticated-orcid":false,"given":"Guojin","family":"Zhou","sequence":"first","affiliation":[{"name":"Guangxi Medical University Cancer Hospital","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Sun Yat-Sen University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuxian","family":"Guo","sequence":"additional","affiliation":[{"name":"Sun Yat-sen University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[{"name":"Dermatology Hospital of Southern Medical University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,10,19]]},"reference":[{"key":"e_1_3_8_3_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834"},{"key":"e_1_3_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104762"},{"key":"e_1_3_8_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-021-00839-w"},{"key":"e_1_3_8_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1913662"},{"key":"e_1_3_8_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4918"},{"key":"e_1_3_8_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-025-01085-z"},{"key":"e_1_3_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2022.05.006"},{"key":"e_1_3_8_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2306434"},{"key":"e_1_3_8_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2510308"},{"key":"e_1_3_8_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70083"},{"key":"e_1_3_8_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-026-01535-1"},{"key":"e_1_3_8_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-067975"},{"key":"e_1_3_8_15_1","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112152-20250511-00215"},{"key":"e_1_3_8_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-12-9"},{"key":"e_1_3_8_17_1","unstructured":"Other hybrid methods [cited 2026 16 March]. Available from: https:\/\/icon-in-r.github.io\/surv-extrapolation\/other-hybrid-methods.html"},{"issue":"2","key":"e_1_3_8_18_1","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jtho.2017.10.012","article-title":"Cost-effectiveness of osimertinib for EGFR mutation-positive non-small cell lung cancer after progression following first-line EGFR TKI therapy","volume":"13","author":"Wu B","year":"2018","unstructured":"Wu B, Gu X, Zhang Q. Cost-effectiveness of osimertinib for EGFR mutation-positive non-small cell lung cancer after progression following first-line EGFR TKI therapy. J Thorac Oncol. 2018;13(2):184\u2013193.","journal-title":"J Thorac Oncol"},{"key":"e_1_3_8_19_1","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S334643"},{"key":"e_1_3_8_20_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.956792"},{"key":"e_1_3_8_21_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1051484"},{"key":"e_1_3_8_22_1","doi-asserted-by":"publisher","DOI":"10.2217\/cer-2017-0069"},{"issue":"5","key":"e_1_3_8_23_1","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1111\/ajco.12477","article-title":"Health state utilities in non-small cell lung cancer: an international study","volume":"13","author":"Nafees B","year":"2017","unstructured":"Nafees B, Lloyd AJ, Dewilde S, et al. Health state utilities in non-small cell lung cancer: an international study. Asia Pac J Clin Oncol. 2017;13(5):e195\u2013e203.","journal-title":"Asia Pac J Clin Oncol"},{"key":"e_1_3_8_24_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2018-0150"},{"key":"e_1_3_8_25_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.920479"},{"key":"e_1_3_8_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-025-13322-3"},{"key":"e_1_3_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.10.640"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14796694.2026.2750655","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14796694.2026.2750655","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14796694.2026.2750655","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:23:10Z","timestamp":1792401790000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14796694.2026.2750655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,19]]},"references-count":25,"alternative-id":["10.1080\/14796694.2026.2750655"],"URL":"https:\/\/doi.org\/10.1080\/14796694.2026.2750655","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,19]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-04-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}